ArticleInternational journal of colorectal disease2026
Clinicopathological characteristics and outcomes of rectal neuroendocrine tumors according to resection modality.
Article in International journal of colorectal disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThis study aimed to compare the effects of different treatment methods on the postoperative results and long-term prognosis of patients with 1-2 cm rectal neuroendocrine tumors (R-NETs), and provide evidence-based guidance for the treatment decision-making of this specific tumor size.
methodsThe retrospective cohort study of this single-center included 736 patients with pathologically diagnosed R-NETs who were treated from January 2013 to August 2024. According to the treatment received, the patients were divided into endoscopic resection group (ER), local surgery group (LS) and radical surgery group (RS). The primary endpoint was recurrence free survival (RFS).
resultsA total of 736 R-NETs patients were enrolled. For the controversial 1-2 cm tumor, there was no significant difference in the long-term RFS between the LS group and the ER group (P = 0.280), and the postoperative hospitalization days of the LS group was relatively short (median 2 days vs. 3 days, P < 0.001). Sensitivity analysis using propensity score matching (PSM) further confirmed these outcomes in postoperative hospitalization days (P < 0.001).
conclusionFor 1-2 cm R-NETs, recurrence events were rare in both treatment groups, and local surgery was associated with a shorter postoperative hospital stay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.